WebNov 25, 2003 · Introduction: Menopausal problems are among the most prevalent and distressing problems following breast cancer treatment, with 70% women experiencing hot flushes and night sweats (HFNS). A working party was set up to support the development of new research into the management of these problems. Methods: We conducted surveys … Web75 mg Effexor (96 women) placebo (sugar pill) (146 women) After 8 weeks, the number of hot flashes per day most women were having dropped from eight to four -- a 50% decrease. The researchers found that: HRT reduced hot flashes by 52.9%. Effexor reduced hot flashes by 47.6%. Placebo reduced hot flashes by 28.6%.

Hot flashes - Symptoms and causes - Mayo Clinic

WebInitial pilot studies 3, 4, 6 reported 50 to 67 percent decreases in hot flashes among women with a history of breast cancer; these results prompted larger studies. In a randomized crossover study ... WebMar 31, 2024 · Hot flashes are caused by a decrease in estrogen. When estrogen levels drop or estrogen receptors are blocked, the body’s temperature control system gets confused and the result is hot flashes. Hot flashes are a symptom of menopause. If … switches purpose

Hot Flashes and Sweating American Cancer Society

WebGabapentin (300 mg, 3 times daily) is another nonhormonal option for treating hot flashes. Watch for future articles in Menopause Flashes that will discuss other distressing … WebBackground: Classical hormone replacement therapy for hot flashes is contraindicated in breast cancer especially in endocrine responsive disease.Patients and methods: In a double-blind, randomized phase III study, breast cancer patients suffering from hot flashes at least twice a day, who were not taking any medication against hypertension and … WebJul 9, 2003 · Hot flashes are the primary reason that women seek medical attention for menopausal symptoms. The recent results from the Women's Health Initiative 1 and long … switches protocol